Aspirin/Caffeine/Acetaminophen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of migraine.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults should take 2 caplets with a full glass of water. The maximum dosage should not exceed 2 caplets within a 24-hour period, unless otherwise directed by a healthcare professional.

For individuals under 18 years of age, it is advised to consult a doctor prior to use. In cases where symptoms persist or worsen, patients should seek medical advice.

Contraindications

Use is contraindicated in individuals with a history of allergic reactions to acetaminophen, aspirin, or any other pain reliever or fever reducer. Additionally, this product should not be used concurrently with any other medication containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in a medication, consultation with a healthcare professional is advised.

Warnings and Precautions

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. The use of this product in these populations may pose significant health risks. If any changes in behavior accompanied by nausea and vomiting occur while using this product, it is imperative to consult a healthcare professional immediately, as these symptoms may indicate the onset of Reye’s syndrome, a rare but serious condition.

In the event of an overdose, it is crucial to seek emergency medical assistance or contact a Poison Control Center without delay. Prompt medical attention is essential for both adults and children, even if no immediate signs or symptoms are apparent.

Healthcare professionals should advise patients to discontinue use and contact their doctor if any of the following occur: an allergic reaction, which necessitates immediate medical attention; signs of stomach bleeding, including feeling faint, vomiting blood, passing bloody or black stools, or experiencing persistent stomach pain; a migraine that is not alleviated or worsens after the first dose; the emergence of new or unexpected symptoms; or the occurrence of tinnitus or hearing loss. Monitoring for these symptoms is vital to ensure patient safety and effective management of potential adverse effects.

Side Effects

Patients using this product should be aware of the potential for serious adverse reactions, including Reye’s syndrome. This condition is particularly concerning in children and teenagers who have or are recovering from chickenpox or flu-like symptoms. If patients experience changes in behavior accompanied by nausea and vomiting while using this product, they should consult a healthcare professional immediately, as these symptoms may indicate the onset of Reye’s syndrome, a rare but serious illness.

Patients are advised to discontinue use and seek medical attention if they experience any signs of an allergic reaction or symptoms indicative of stomach bleeding. These symptoms include feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain. Additionally, if a migraine is not relieved or worsens after the first dose, or if new or unexpected symptoms arise, patients should contact their healthcare provider. Patients should also be alert to any occurrences of ringing in the ears or loss of hearing.

Before using this product, patients should consult a healthcare professional if they have never had migraines diagnosed by a health professional, if they experience a headache that differs from their usual migraines, or if they have the worst headache of their life. Other conditions that warrant consultation include fever and stiff neck, headaches that begin after or are caused by head injury, exertion, coughing, or bending, and experiencing a first headache after the age of 50. Patients with daily headaches, severe migraines requiring bed rest, liver disease, or a history of stomach problems such as heartburn should also seek medical advice prior to use.

Furthermore, patients with high blood pressure, heart disease, liver cirrhosis, or kidney disease, as well as those taking diuretics or who have asthma, should consult a healthcare provider. It is also important for patients who have experienced serious side effects from pain relievers or fever reducers, or who experience vomiting with their migraine headache, to seek medical advice before using this product.

Patients taking prescription medications for diabetes, gout, or arthritis, or those under a doctor’s care for any serious condition, should consult a healthcare professional before use. Additionally, patients should inform their healthcare provider if they are taking any other medications or products that contain aspirin, acetaminophen, or any other pain reliever or fever reducer.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Acetaminophen, Aspirin and Caffeine. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product due to the risk of Reye’s syndrome. Healthcare professionals should advise that if any changes in behavior accompanied by nausea and vomiting occur while using this product, a doctor should be consulted, as these symptoms may indicate the onset of Reye’s syndrome, a rare but serious condition.

For pediatric patients under 18 years of age, it is recommended to consult a doctor before use.

Geriatric Use

Elderly patients, particularly those aged 60 years and older, may have an increased risk of severe stomach bleeding. Healthcare providers should exercise caution when prescribing this medication to geriatric patients, considering the potential for heightened adverse effects.

It is advisable to closely monitor elderly patients for any signs of gastrointestinal bleeding and to evaluate the necessity of dosage adjustments based on individual patient factors. Careful assessment of the risk-benefit ratio is essential in this population to ensure safe and effective use of the medication.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The use of aspirin during pregnancy, particularly at 20 weeks gestation or later, is associated with potential risks. Specifically, it may lead to adverse effects on fetal outcomes or complications during delivery. Therefore, it is crucial that pregnant patients only use aspirin under the guidance of a healthcare provider if deemed necessary.

Lactation

Lactating mothers are advised to consult a health professional before using this medication. It is particularly important to avoid the use of aspirin at 20 weeks of gestation or later, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment may not have specific information regarding dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Monitoring of vital signs and laboratory parameters may be warranted to assess the patient's condition and guide further management.

Healthcare professionals should remain vigilant for potential symptoms that could indicate an overdosage scenario, although specific symptoms have not been detailed. If any adverse reactions or unexpected clinical presentations occur, appropriate medical intervention should be sought immediately.

For further guidance, healthcare providers are encouraged to consult local poison control centers or relevant medical authorities to obtain the most current recommendations for managing suspected overdosage cases.

Nonclinical Toxicology

It is especially important not to use aspirin at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No specific postmarketing experience details have been reported in the available data. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical help or contact a Poison Control Center in the event of an overdose, as prompt medical attention is crucial for both adults and children, even if no signs or symptoms are initially apparent.

Patients should be informed not to use this medication if they have a history of allergic reactions to acetaminophen, aspirin, or any other pain reliever or fever reducer. It is essential to avoid concurrent use with any other medications containing acetaminophen, whether prescription or nonprescription. If patients are uncertain about the contents of a medication, they should be encouraged to consult a doctor or pharmacist.

Patients must be instructed to discontinue use and consult a doctor if they experience any signs of an allergic reaction or if they notice symptoms indicative of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain. Additionally, if a migraine is not relieved or worsens after the first dose, or if new or unexpected symptoms arise, patients should seek medical advice. They should also be made aware of the importance of reporting any ringing in the ears or loss of hearing.

Before initiating treatment, healthcare providers should recommend that patients consult a doctor if they have never had migraines diagnosed by a health professional, if they experience headaches that differ from their usual migraines, or if they have the worst headache of their life. Patients should also be advised to seek medical advice if they have a fever accompanied by a stiff neck, headaches that begin after or are caused by head injury, exertion, coughing, or bending, or if they experience their first headache after the age of 50. Those with daily headaches or migraines severe enough to require bed rest should also consult a doctor prior to use.

Patients with liver disease, a history of stomach problems such as heartburn, high blood pressure, heart disease, liver cirrhosis, or kidney disease should be advised to seek medical consultation before using this medication. Additionally, patients taking diuretics, those with asthma, or individuals who have experienced serious side effects from pain relievers or fever reducers should be encouraged to discuss their situation with a healthcare provider.

Patients experiencing vomiting with their migraine headache should also consult a doctor before use. Furthermore, it is important for patients to discuss any prescription medications they are taking for diabetes, gout, or arthritis with their healthcare provider or pharmacist. Lastly, patients should be reminded to inform their healthcare provider or pharmacist about any other medications or products they are using that contain aspirin, acetaminophen, or any other pain reliever or fever reducer.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It should be stored at a controlled room temperature ranging from 20° to 25°C (68° to 77°F) to maintain its efficacy and stability.

To ensure optimal preservation, it is crucial to close the cap tightly after each use. This practice helps prevent contamination and degradation of the product.

Additional Clinical Information

The route of administration for the medication is oral. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid the use of aspirin at 20 weeks of pregnancy or later unless explicitly directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery.

Drug Information (PDF)

This file contains official product information for Acetaminophen, Aspirin and Caffeine, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)